Medicinal product name Opdivo
Pharmaceutical form Concentrate for solution for infusion
Strength 10 mg/ml 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.II onk. ķīm. ter.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code L01FF01 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(40 mg/4 ml)
Glass vial    EU/1/15/1014/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/15/1014/001
Date of authorisation Jun 19, 2015
Marketing authorisation holder, country Bristol-Myers Squibb Pharma EEIG, Ireland